Skip to content

Clinical trial to determine the anti hairfall effect of Unani formulations(hair serum and hair oil) in subjects with hairfall

A Randomised Comparative clinical trial to Evaluate the Safety and Efficacy of Hair oil and Hair serum of Unani Formulations in Inteshar-e-sharr(Diffuse Hair Fall) - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065550
Enrollment
60
Registered
2024-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

Intervention1: Hair serum(unani formulation): Patient will be asked for hair fall hair damage .Hair serum with unani formulation will be apply on scalp every night.hair serum contain amla ,barg e azad

Sponsors

Dept of Amraz e Jild wa Zohrawiya Aligarh Muslim University Aligarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Nutritional deficiency. Complaining of Hair fall and hair damage, agree to refrain from using hair dye/hair oil ,spa treatment or hair straightening were included. If patient dont come to visit on the given date then we reinclude the patient within 10 days.

Exclusion criteria

Exclusion criteria: subjects who have undergone hair growth treatment within three months before screening. Who have scalp diseases . Have a history of psychiatric diseases such as Trichotillomania. Pregnant and lactating women. Patients with co-morbid conditions like CKD ,DM. Patients with secondary infected lesion . Patients who do not followthe prescribed schedule. Patients who do not want to fill consent form.

Design outcomes

Primary

MeasureTime frame
Changes in Hair Shedding Visual Scale (HSVS)scale in every 15 days for three weeks.Timepoint: Changes in Hair Shedding Visual Scale (HSVS)scale in every 15 days for three weeks.

Secondary

MeasureTime frame
Improvement in the Subjective parameters assessed clinically.Timepoint: After three weeks.

Countries

India

Contacts

Public ContactSADIA SADAF

Department of Amraz-e-jild wa zohrawiya,Faculty of Unani Medicine

drzamiramrohi@gmail.com8475007594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026